Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study GroupNicolas Moosmann, Volker Heinemann, Sebastian Stintzing et al.|Journal of Clinical Oncology|2011Cited by 117